**Abstract**

**Introduction:** In drug therapy with long-acting injection (LAI) of antipsychotics, the drug level is maintained by injection every 2--4 weeks, and it is effective for the rehabilitation in schizophrenia patients. In this study, Changes of oxy-Hb concentration during verbal (shiritori and word production) tasks was compared among schizophrenia outpatients attending our hospital before and after one-year administration of LAI antipsychotics, those treated with conventional oral drugs.

**Methods:** Subjects were 15 schizophrenic outpatients (32.6 ± 7.7 years old) attending Kurume University Hospital diagnosed by ICD-10 and age-matched 15 healthy subjects. Symptoms were evaluated using PANSS.

Oxy-Hb value during the tasks were measured at bilateral recording points (22 on each side) using a multi-channel NIRS system. The subjects were instructed to phonate "a-i-u-e-o" for 12 seconds as a resting condition, and performed a verbal production task (VPT) or shiritori task (saying a word starting with the last syllable). The shiritori task involved two task patterns, i.e., standard shiritori (VST) and living creatures shiritori (VLT). From the data obtained at each measurement point during the 20 trials, an averaged waveform was prepared, and peak values of waveform were calculated and analyzed.

**Results:** On comparison between before and after LAI antipsychotics administration, PANSS score significantly decreased after one year. No significant difference was noted in the number of words in the verbal tasks between before and after administration. Oxy-Hb value was significantly increased in the left frontal region after one-year administration compared with that before administration during the VST and VPT, but no significant change was noted in the VLT. On self-evaluation, 11 patients and all families evaluated that it was good to use LAI antipsychotics.

**Discussion:** It was suggested that LAI antipsychotics are effective, and oxy-Hb value on NIRS serves as a useful psychophysiological index to evaluate drugs.
